Synthetic RORγt Agonists Enhance Protective Immunity

ACS Chemical Biology

Volumn 11, Issue 4, 2016, Pages 1012-1018

  Chang, Mi Ra ^a   Dharmarajan, Venkatasubramanian ^a   Doebelin, Christelle ^a   Garcia Ordonez, Ruben D ^a   Novick, Scott J ^a   Kuruvilla, Dana S ^a   Kamenecka, Theodore M ^a   Griffin, Patrick R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTINEOPLASTIC AGENT; DESMOSTEROL; INTERLEUKIN 17; PROGRAMMED DEATH 1 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; SR 0987; UNCLASSIFIED DRUG; URSOLIC ACID; RORC PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SYNTHESIS; EC50; HEK293 CELL LINE; HUMAN; HUMAN CELL; IC50; IMMUNITY; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; JURKAT CELL LINE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; AGONISTS; CELL PROLIFERATION; CELLULAR IMMUNITY; DRUG EFFECTS;

CELL PROLIFERATION; HUMANS; IMMUNITY, CELLULAR; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3;

EID: 84966340249     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.5b00899     Document Type: Article

References (33)

1. Huang, Z., Xie, H., Wang, R., and Sun, Z. (2007) Retinoid-related orphan receptor gamma t is a potential therapeutic target for controlling inflammatory autoimmunity Expert Opin. Ther. Targets 11, 737-743 10.1517/14728222.11.6.737
2. Wang, Y., Kumar, N., Solt, L. A., Richardson, T. I., Helvering, L. M., Crumbley, C., Garcia-Ordonez, R. D., Stayrook, K. R., Zhang, X., Novick, S., Chalmers, M. J., Griffin, P. R., and Burris, T. P. (2010) Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands J. Biol. Chem. 285, 5013-5025 10.1074/jbc.M109.080614
3. Hu, X., Wang, Y., Hao, L. Y., Liu, X., Lesch, C. A., Sanchez, B. M., Wendling, J. M., Morgan, R. W., Aicher, T. D., Carter, L. L., Toogood, P. L., and Glick, G. D. (2015) Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists Nat. Chem. Biol. 11, 141-147 10.1038/nchembio.1714
4. Santori, F. R., Huang, P., van de Pavert, S. A., Douglass, E. F., Jr., Leaver, D. J., Haubrich, B. A., Keber, R., Lorbek, G., Konijn, T., Rosales, B. N., Rozman, D., Horvat, S., Rahier, A., Mebius, R. E., Rastinejad, F., Nes, W. D., and Littman, D. R. (2015) Identification of natural RORgamma ligands that regulate the development of lymphoid cells Cell Metab. 21, 286-297 10.1016/j.cmet.2015.01.004
5. Sun, Z., Unutmaz, D., Zou, Y. R., Sunshine, M. J., Pierani, A., Brenner-Morton, S., Mebius, R. E., and Littman, D. R. (2000) Requirement for RORgamma in thymocyte survival and lymphoid organ development Science 288, 2369-2373 10.1126/science.288.5475.2369
6. Skepner, J., Ramesh, R., Trocha, M., Schmidt, D., Baloglu, E., Lobera, M., Carlson, T., Hill, J., Orband-Miller, L. A., Barnes, A., Boudjelal, M., Sundrud, M., Ghosh, S., and Yang, J. (2014) Pharmacologic inhibition of RORgammat regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo J. Immunol. 192, 2564-2575 10.4049/jimmunol.1302190
7. Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., Chang, A., Coukos, G., Liu, R., and Zou, W. (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114, 1141-1149 10.1182/blood-2009-03-208249
8. Yen, H. R., Harris, T. J., Wada, S., Grosso, J. F., Getnet, D., Goldberg, M. V., Liang, K. L., Bruno, T. C., Pyle, K. J., Chan, S. L., Anders, R. A., Trimble, C. L., Adler, A. J., Lin, T. Y., Pardoll, D. M., Huang, C. T., and Drake, C. G. (2009) Tc17 CD8 T cells: functional plasticity and subset diversity J. Immunol. 183, 7161-7168 10.4049/jimmunol.0900368
9. Twyman-Saint Victor, C., Rech, A. J., Maity, A., Rengan, R., Pauken, K. E., Stelekati, E., Benci, J. L., Xu, B., Dada, H., Odorizzi, P. M., Herati, R. S., Mansfield, K. D., Patsch, D., Amaravadi, R. K., Schuchter, L. M., Ishwaran, H., Mick, R., Pryma, D. A., Xu, X., Feldman, M. D., Gangadhar, T. C., Hahn, S. M., Wherry, E. J., Vonderheide, R. H., and Minn, A. J. (2015) Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer Nature 520, 373-377 10.1038/nature14292
10. Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W. J., Mulder, G. E., Toebes, M., Vesely, M. D., Lam, S. S., Korman, A. J., Allison, J. P., Freeman, G. J., Sharpe, A. H., Pearce, E. L., Schumacher, T. N., Aebersold, R., Rammensee, H. G., Melief, C. J., Mardis, E. R., Gillanders, W. E., Artyomov, M. N., and Schreiber, R. D. (2014) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens Nature 515, 577-581 10.1038/nature13988
11. Zou, W. and Restifo, N. P. (2010) T(H)17 cells in tumour immunity and immunotherapy Nat. Rev. Immunol. 10, 248-256 10.1038/nri2742
12. Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., Leming, P. D., Spigel, D. R., Antonia, S. J., Horn, L., Drake, C. G., Pardoll, D. M., Chen, L., Sharfman, W. H., Anders, R. A., Taube, J. M., McMiller, T. L., Xu, H., Korman, A. J., Jure-Kunkel, M., Agrawal, S., McDonald, D., Kollia, G. D., Gupta, A., Wigginton, J. M., and Sznol, M. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N. Engl. J. Med. 366, 2443-2454 10.1056/NEJMoa1200690
13. Brahmer, J. R., Tykodi, S. S., Chow, L. Q., Hwu, W. J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., Pitot, H. C., Hamid, O., Bhatia, S., Martins, R., Eaton, K., Chen, S., Salay, T. M., Alaparthy, S., Grosso, J. F., Korman, A. J., Parker, S. M., Agrawal, S., Goldberg, S. M., Pardoll, D. M., Gupta, A., and Wigginton, J. M. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N. Engl. J. Med. 366, 2455-2465 10.1056/NEJMoa1200694
14. Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., Dronca, R., Gangadhar, T. C., Patnaik, A., Zarour, H., Joshua, A. M., Gergich, K., Elassaiss-Schaap, J., Algazi, A., Mateus, C., Boasberg, P., Tumeh, P. C., Chmielowski, B., Ebbinghaus, S. W., Li, X. N., Kang, S. P., and Ribas, A. (2013) Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma N. Engl. J. Med. 369, 134-144 10.1056/NEJMoa1305133
15. Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R. A., Reed, K., Burke, M. M., Caldwell, A., Kronenberg, S. A., Agunwamba, B. U., Zhang, X., Lowy, I., Inzunza, H. D., Feely, W., Horak, C. E., Hong, Q., Korman, A. J., Wigginton, J. M., Gupta, A., and Sznol, M. (2013) Nivolumab plus ipilimumab in advanced melanoma N. Engl. J. Med. 369, 122-133 10.1056/NEJMoa1302369
16. Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., Leming, P. D., Lipson, E. J., Puzanov, I., Smith, D. C., Taube, J. M., Wigginton, J. M., Kollia, G. D., Gupta, A., Pardoll, D. M., Sosman, J. A., and Hodi, F. S. (2014) Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab J. Clin. Oncol. 32, 1020-1030 10.1200/JCO.2013.53.0105
17. Zhang, W., Zhang, J., Fang, L., Zhou, L., Wang, S., Xiang, Z., Li, Y., Wisely, B., Zhang, G., An, G., Wang, Y., Leung, S., and Zhong, Z. (2012) Increasing human Th17 differentiation through activation of orphan nuclear receptor retinoid acid-related orphan receptor gamma (RORgamma) by a class of aryl amide compounds Mol. Pharmacol. 82, 583-590 10.1124/mol.112.078667
18. Wang, Y., Kumar, N., Nuhant, P., Cameron, M. D., Istrate, M. A., Roush, W. R., Griffin, P. R., and Burris, T. P. (2010) Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma ACS Chem. Biol. 5, 1029-1034 10.1021/cb100223d
19. Rene, O., Fauber, B. P., Boenig, G., Burton, B., Eidenschenk, C., Everett, C., Gobbi, A., Hymowitz, S. G., Johnson, A. R., Kiefer, J. R., Liimatta, M., Lockey, P., Norman, M., Ouyang, W., Wallweber, H. A., and Wong, H. (2015) Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action ACS Med. Chem. Lett. 6, 276-281 10.1021/ml500420y
20. Scheepstra, M., Leysen, S., van Almen, G. C., Miller, J. R., Piesvaux, J., Kutilek, V., van Eenennaam, H., Zhang, H., Barr, K., Nagpal, S., Soisson, S. M., Kornienko, M., Wiley, K., Elsen, N., Sharma, S., Correll, C. C., Trotter, B. W., van der Stelt, M., Oubrie, A., Ottmann, C., Parthasarathy, G., and Brunsveld, L. (2015) Identification of an allosteric binding site for RORgammat inhibition Nat. Commun. 6, 8833 10.1038/ncomms9833
21. Kumar, N., Lyda, B., Chang, M. R., Lauer, J. L., Solt, L. A., Burris, T. P., Kamenecka, T. M., and Griffin, P. R. (2012) Identification of SR2211: a potent synthetic RORgamma-selective modulator ACS Chem. Biol. 7, 672-677 10.1021/cb200496y
22. Chang, M. R., Lyda, B., Kamenecka, T. M., and Griffin, P. R. (2014) Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor gamma is therapeutic in the collagen-induced arthritis experimental model Arthritis Rheumatol. 66, 579-588 10.1002/art.38272
23. Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., and Riley, J. L. (2004) SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation J. Immunol. 173, 945-954 10.4049/jimmunol.173.2.945
24. Nishimura, H., Honjo, T., and Minato, N. (2000) Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice J. Exp. Med. 191, 891-898 10.1084/jem.191.5.891
25. Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., and Honjo, T. (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291, 319-322 10.1126/science.291.5502.319
26. Tarrio, M. L., Grabie, N., Bu, D. X., Sharpe, A. H., and Lichtman, A. H. (2012) PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis J. Immunol. 188, 4876-4884 10.4049/jimmunol.1200389
27. Zhang, J., Chalmers, M. J., Stayrook, K. R., Burris, L. L., Garcia-Ordonez, R. D., Pascal, B. D., Burris, T. P., Dodge, J. A., and Griffin, P. R. (2010) Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer Structure 18, 1332-1341 10.1016/j.str.2010.07.007
28. Solt, L. A., Kumar, N., Nuhant, P., Wang, Y., Lauer, J. L., Liu, J., Istrate, M. A., Kamenecka, T. M., Roush, W. R., Vidovic, D., Schurer, S. C., Xu, J., Wagoner, G., Drew, P. D., Griffin, P. R., and Burris, T. P. (2011) Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand Nature 472, 491-494 10.1038/nature10075
29. Marciano, D. P., Kuruvilla, D. S., Boregowda, S. V., Asteian, A., Hughes, T. S., Garcia-Ordonez, R., Corzo, C. A., Khan, T. M., Novick, S. J., Park, H., Kojetin, D. J., Phinney, D. G., Bruning, J. B., Kamenecka, T. M., and Griffin, P. R. (2015) Pharmacological repression of PPARgamma promotes osteogenesis Nat. Commun. 6, 7443 10.1038/ncomms8443
30. Jin, L., Martynowski, D., Zheng, S., Wada, T., Xie, W., and Li, Y. (2010) Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma Mol. Endocrinol. 24, 923-929 10.1210/me.2009-0507
31. Goswami, D., Callaway, C., Pascal, B. D., Kumar, R., Edwards, D. P., and Griffin, P. R. (2014) Influence of domain interactions on conformational mobility of the progesterone receptor detected by hydrogen/deuterium exchange mass spectrometry Structure 22, 961-973 10.1016/j.str.2014.04.013
32. West, G. M., Pascal, B. D., Ng, L. M., Soon, F. F., Melcher, K., Xu, H. E., Chalmers, M. J., and Griffin, P. R. (2013) Protein conformation ensembles monitored by HDX reveal a structural rationale for abscisic acid signaling protein affinities and activities Structure 21, 229-235 10.1016/j.str.2012.12.001
33. Pascal, B. D., Willis, S., Lauer, J. L., Landgraf, R. R., West, G. M., Marciano, D., Novick, S., Goswami, D., Chalmers, M. J., and Griffin, P. R. (2012) HDX workbench: software for the analysis of H/D exchange MS data J. Am. Soc. Mass Spectrom. 23, 1512-1521 10.1007/s13361-012-0419-6